New York state to begin trials of hydroxychloroquine, zithromax, chloroquine to treat coronavirus patients, Gov. Cuomo says
As deaths from coronavirus pandemic climb above 14,000, everyone is talking about a study conducted by French researchers which found that a combination of Hydroxychloroquine (HCQ) and Azithromycin are effective in treating COVID-19 patients. The study conducted in Marseille, France, showed that 100% of patients that received a combination of HCQ and Azithromycin tested negative and were virologically cured within 6 days of treatment.
However, the U.S. has been very cautious about using the drugs in treating COVID-19 patients due to skepticism from the FDA. Now, New York State Gov. Cuomo announced during a press conference today that New York is about to begin trials of antimalaria drugs for treatment of coronavirus. Gov. Cuomo said the federal government has given the state 70,000 doses of hydroxychloroquine, 10,000 doses of zithromax and 750,000 doses of chloroquine. Testing will kick off Tuesday, Cuomo said.
“The president is optimistic about these drugs and we are all optimistic that it could work,” the governor said at a press conference. “I’ve spoken with a number of health officials and there is a good basis to believe that they could work.”